Literature DB >> 27903161

A Call for Saving Interdisciplinary Pain Management.

Xiulu Ruan, Alan David Kaye.   

Abstract

Chronic pain is pervasive and costly. In 2011, the Institute of Medicine (IOM) released a landmark report on chronic pain, which estimated that more than 100 million Americans suffer from chronic pain, making pain a major and significant public health problem. The benefits of interdisciplinary pain management programs are undeniable and have been demonstrated for over a half century. Until health care leaders and other stakeholders such as insurers work together to ensure best practices in pain management, we will certainly end up in a lose-lose situation for both the health care teams and patients. In order to impact health care policy more effectively, we need to better understand the politics of health policy decision making. J Orthop Sports Phys Ther 2016;46(12):1021-1023. doi:10.2519/jospt.2016.0611.

Entities:  

Keywords:  chronic pain; interdisciplinary; pain management

Mesh:

Year:  2016        PMID: 27903161     DOI: 10.2519/jospt.2016.0611

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  3 in total

1.  The role of dorsal root ganglia alpha-7 nicotinic acetylcholine receptor in complete Freund's adjuvant-induced chronic inflammatory pain.

Authors:  Xiaoyu Zhang; Fangxia Xu; Lijuan Wang; Jinbao Li; Jianhai Zhang; Lina Huang
Journal:  Inflammopharmacology       Date:  2021-09-12       Impact factor: 4.473

2.  A Comprehensive, Multimodal, Interdisciplinary Approach to Chronic Non-Cancer Pain Management in a Family Medicine Clinic: A Retrospective Cohort Review.

Authors:  Edward Kwon; Christopher Stange; Katy Reichlin; Hamilton Vernon; Akira Miyanari; Elizabeth Bier; Hind Beydoun; Virginia Kalish
Journal:  Perm J       Date:  2021-10-29

Review 3.  An Association of Serotonin with Pain Disorders and Its Modulation by Estrogens.

Authors:  Stephania Paredes; Santiago Cantillo; Kenneth D Candido; Nebojsa Nick Knezevic
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.